English
简体中文
Total: £ 56.28
Published Date: 2025-08-07 | Pages: 76 | Tables: 77 | Medical Care
The global Organoids market size was US$ 67 million in 2024 and is forecast to a readjusted size of US$ 215 million by 2031 with a CAGR of 18.4% during the forecast period 2025-2031.
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality.
Organoids are a complex collection of cells grown in 3D culture medium that can summarize the various physiological and genomic characteristics of various tissues or organs. Organoids are micro-organs with three-dimensional structures that are cultivated in vitro using adult stem cells. They have highly similar genetic backgrounds and histological characteristics to organs in the body; they have complex structures similar to real organs and can partially simulate the physiological functions of the source tissues and organs; they simulate the endogenous environment to conduct research on tissue biology, development and regeneration, disease modeling, organ transplantation technology improvement, drug discovery/efficacy evaluation, and toxicology. Organoids refer to tissue analogs with a certain spatial structure formed by three-dimensional (3D) culture in vitro using adult stem cells or pluripotent stem cells. Although organoids are not true human organs, they can simulate real organs in structure and function, can simulate the structure and function of in vivo tissues to the greatest extent, and can be cultured stably for a long time (hence they are also called "micro-organs").
A major driver of the organoids market is the increasing demand for advanced models in drug discovery and personalized medicine. Organoids, which mimic the structure and function of real human organs, provide a more accurate representation of human biology compared to traditional cell cultures or animal models. This enables pharmaceutical companies to conduct more precise preclinical testing, reducing the time and cost of drug development. Additionally, organoids are being increasingly used in personalized medicine, where they can help tailor treatments to individual patients by predicting how they will respond to specific therapies, particularly in cancer research.
One of the main challenges in the organoids market is the complexity and high cost of organoid development and maintenance. Creating organoids that accurately replicate human organs requires sophisticated techniques and specialized equipment, making the process expensive and technically demanding. Additionally, there are still limitations in scaling up production and standardizing protocols, which hinders widespread adoption in clinical settings. Regulatory hurdles and the need for more validation studies to ensure the reliability of organoids in predicting human responses also pose barriers to market growth.
The global Organoids market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Tanwang Medical
Ketu Medicine
Chuangxin International
By Type: (Dominant Segment vs High-Margin Innovation)
Stem Cell Source
Tumor Cell Source
By Application: (Core Demand Driver vs Emerging Opportunity)
Precision Medicine
Pharmaceutical R&D
Academics and Research Institutes
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Thermo Fisher Scientific in Europe)
- Emerging Product Trends: Stem Cell Source adoption vs. Tumor Cell Source premiumization
- Demand-Side Dynamics: Precision Medicine growth in China vs. Pharmaceutical R&D potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Organoids market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Tumor Cell Source in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical R&D in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Organoids value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Source
1.2.3 Tumor Cell Source
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Precision Medicine
1.3.3 Pharmaceutical R&D
1.3.4 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organoids Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Organoids Revenue Market Share by Region (2020-2025)
2.4 Global Organoids Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Organoids Market Size and Prospective (2020-2031)
2.5.2 Europe Organoids Market Size and Prospective (2020-2031)
2.5.3 China Organoids Market Size and Prospective (2020-2031)
2.5.4 Japan Organoids Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Organoids Historic Market Size by Type (2020-2025)
3.2 Global Organoids Forecasted Market Size by Type (2026-2031)
3.3 Different Types Organoids Representative Players
4 Breakdown Data by Application
4.1 Global Organoids Historic Market Size by Application (2020-2025)
4.2 Global Organoids Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Organoids Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Organoids Players by Revenue (2020-2025)
5.1.2 Global Organoids Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Organoids Revenue
5.4 Global Organoids Market Concentration Analysis
5.4.1 Global Organoids Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Organoids Revenue in 2024
5.5 Global Key Players of Organoids Head office and Area Served
5.6 Global Key Players of Organoids, Product and Application
5.7 Global Key Players of Organoids, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Organoids Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Organoids Market Size by Type (2020-2025)
6.1.2.2 North America Organoids Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Organoids Market Size by Application (2020-2025)
6.1.3.2 North America Organoids Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Organoids Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Organoids Market Size by Type (2020-2025)
6.2.2.2 Europe Organoids Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Organoids Market Size by Application (2020-2025)
6.2.3.2 Europe Organoids Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Organoids Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Organoids Market Size by Type (2020-2025)
6.3.2.2 China Organoids Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Organoids Market Size by Application (2020-2025)
6.3.3.2 China Organoids Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Organoids Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Organoids Market Size by Type (2020-2025)
6.4.2.2 Japan Organoids Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Organoids Market Size by Application (2020-2025)
6.4.3.2 Japan Organoids Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Organoids Introduction
7.1.4 Thermo Fisher Scientific Revenue in Organoids Business (2020-2025)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck Organoids Introduction
7.2.4 Merck Revenue in Organoids Business (2020-2025)
7.2.5 Merck Recent Development
7.3 Corning
7.3.1 Corning Company Details
7.3.2 Corning Business Overview
7.3.3 Corning Organoids Introduction
7.3.4 Corning Revenue in Organoids Business (2020-2025)
7.3.5 Corning Recent Development
7.4 STEMCELL Technologies
7.4.1 STEMCELL Technologies Company Details
7.4.2 STEMCELL Technologies Business Overview
7.4.3 STEMCELL Technologies Organoids Introduction
7.4.4 STEMCELL Technologies Revenue in Organoids Business (2020-2025)
7.4.5 STEMCELL Technologies Recent Development
7.5 Lonza
7.5.1 Lonza Company Details
7.5.2 Lonza Business Overview
7.5.3 Lonza Organoids Introduction
7.5.4 Lonza Revenue in Organoids Business (2020-2025)
7.5.5 Lonza Recent Development
7.6 Prellis Biologics
7.6.1 Prellis Biologics Company Details
7.6.2 Prellis Biologics Business Overview
7.6.3 Prellis Biologics Organoids Introduction
7.6.4 Prellis Biologics Revenue in Organoids Business (2020-2025)
7.6.5 Prellis Biologics Recent Development
7.7 amsbio
7.7.1 amsbio Company Details
7.7.2 amsbio Business Overview
7.7.3 amsbio Organoids Introduction
7.7.4 amsbio Revenue in Organoids Business (2020-2025)
7.7.5 amsbio Recent Development
7.8 Tanwang Medical
7.8.1 Tanwang Medical Company Details
7.8.2 Tanwang Medical Business Overview
7.8.3 Tanwang Medical Organoids Introduction
7.8.4 Tanwang Medical Revenue in Organoids Business (2020-2025)
7.8.5 Tanwang Medical Recent Development
7.9 Ketu Medicine
7.9.1 Ketu Medicine Company Details
7.9.2 Ketu Medicine Business Overview
7.9.3 Ketu Medicine Organoids Introduction
7.9.4 Ketu Medicine Revenue in Organoids Business (2020-2025)
7.9.5 Ketu Medicine Recent Development
7.10 Chuangxin International
7.10.1 Chuangxin International Company Details
7.10.2 Chuangxin International Business Overview
7.10.3 Chuangxin International Organoids Introduction
7.10.4 Chuangxin International Revenue in Organoids Business (2020-2025)
7.10.5 Chuangxin International Recent Development
8 Organoids Market Dynamics
8.1 Organoids Industry Trends
8.2 Organoids Market Drivers
8.3 Organoids Market Challenges
8.4 Organoids Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Organoids Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Organoids Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Organoids Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Organoids Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Organoids Revenue Share by Region (2020-2025)
Table 6. Global Organoids Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Organoids Revenue Share Forecast by Region (2026-2031)
Table 8. Global Organoids Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Organoids Revenue Market Share by Type (2020-2025)
Table 10. Global Organoids Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Organoids Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Organoids Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Organoids Revenue Market Share by Application (2020-2025)
Table 15. Global Organoids Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Organoids Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Organoids Application
Table 18. Global Organoids Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Organoids Market Share by Players (2020-2025)
Table 20. Global Top Organoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2024)
Table 21. Ranking of Global Top Organoids Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Organoids Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Organoids, Headquarters and Area Served
Table 24. Global Key Players of Organoids, Product and Application
Table 25. Global Key Players of Organoids, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Organoids Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Organoids Revenue Market Share by Company (2020-2025)
Table 29. North America Organoids Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Organoids Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Organoids Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Organoids Revenue Market Share by Company (2020-2025)
Table 33. Europe Organoids Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Organoids Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Organoids Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Organoids Revenue Market Share by Company (2020-2025)
Table 37. China Organoids Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Organoids Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Organoids Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Organoids Revenue Market Share by Company (2020-2025)
Table 41. Japan Organoids Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Organoids Market Size by Application (2020-2025) & (US$ Million)
Table 43. Thermo Fisher Scientific Company Details
Table 44. Thermo Fisher Scientific Business Overview
Table 45. Thermo Fisher Scientific Organoids Product
Table 46. Thermo Fisher Scientific Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 47. Thermo Fisher Scientific Recent Development
Table 48. Merck Company Details
Table 49. Merck Business Overview
Table 50. Merck Organoids Product
Table 51. Merck Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Corning Company Details
Table 54. Corning Business Overview
Table 55. Corning Organoids Product
Table 56. Corning Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 57. Corning Recent Development
Table 58. STEMCELL Technologies Company Details
Table 59. STEMCELL Technologies Business Overview
Table 60. STEMCELL Technologies Organoids Product
Table 61. STEMCELL Technologies Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 62. STEMCELL Technologies Recent Development
Table 63. Lonza Company Details
Table 64. Lonza Business Overview
Table 65. Lonza Organoids Product
Table 66. Lonza Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 67. Lonza Recent Development
Table 68. Prellis Biologics Company Details
Table 69. Prellis Biologics Business Overview
Table 70. Prellis Biologics Organoids Product
Table 71. Prellis Biologics Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 72. Prellis Biologics Recent Development
Table 73. amsbio Company Details
Table 74. amsbio Business Overview
Table 75. amsbio Organoids Product
Table 76. amsbio Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 77. amsbio Recent Development
Table 78. Tanwang Medical Company Details
Table 79. Tanwang Medical Business Overview
Table 80. Tanwang Medical Organoids Product
Table 81. Tanwang Medical Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 82. Tanwang Medical Recent Development
Table 83. Ketu Medicine Company Details
Table 84. Ketu Medicine Business Overview
Table 85. Ketu Medicine Organoids Product
Table 86. Ketu Medicine Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 87. Ketu Medicine Recent Development
Table 88. Chuangxin International Company Details
Table 89. Chuangxin International Business Overview
Table 90. Chuangxin International Organoids Product
Table 91. Chuangxin International Revenue in Organoids Business (2020-2025) & (US$ Million)
Table 92. Chuangxin International Recent Development
Table 93. Organoids Market Trends
Table 94. Organoids Market Drivers
Table 95. Organoids Market Challenges
Table 96. Organoids Market Restraints
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Organoids Product Picture
Figure 2. Global Organoids Market Share by Type: 2024 VS 2031
Figure 3. Stem Cell Source Features
Figure 4. Tumor Cell Source Features
Figure 5. Global Organoids Market Share by Application: 2024 VS 2031
Figure 6. Precision Medicine
Figure 7. Pharmaceutical R&D
Figure 8. Academics and Research Institutes
Figure 9. Organoids Report Years Considered
Figure 10. Global Organoids Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Organoids Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Organoids Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Organoids Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Organoids Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Organoids Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Organoids Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Global Organoids Market Share by Players in 2024
Figure 18. Global Top Organoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Organoids Revenue in 2024
Figure 20. North America Organoids Market Share by Type (2020-2025)
Figure 21. North America Organoids Market Share by Application (2020-2025)
Figure 22. Europe Organoids Market Share by Type (2020-2025)
Figure 23. Europe Organoids Market Share by Application (2020-2025)
Figure 24. China Organoids Market Share by Type (2020-2025)
Figure 25. China Organoids Market Share by Application (2020-2025)
Figure 26. Japan Organoids Market Share by Type (2020-2025)
Figure 27. Japan Organoids Market Share by Application (2020-2025)
Figure 28. Thermo Fisher Scientific Revenue Growth Rate in Organoids Business (2020-2025)
Figure 29. Merck Revenue Growth Rate in Organoids Business (2020-2025)
Figure 30. Corning Revenue Growth Rate in Organoids Business (2020-2025)
Figure 31. STEMCELL Technologies Revenue Growth Rate in Organoids Business (2020-2025)
Figure 32. Lonza Revenue Growth Rate in Organoids Business (2020-2025)
Figure 33. Prellis Biologics Revenue Growth Rate in Organoids Business (2020-2025)
Figure 34. amsbio Revenue Growth Rate in Organoids Business (2020-2025)
Figure 35. Tanwang Medical Revenue Growth Rate in Organoids Business (2020-2025)
Figure 36. Ketu Medicine Revenue Growth Rate in Organoids Business (2020-2025)
Figure 37. Chuangxin International Revenue Growth Rate in Organoids Business (2020-2025)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
